| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.3 | 0.004 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |